Serum butyrylcholinesterase and paraoxonase 1 in a canine model of endotoxemia: Effects of choline administration

Research in Veterinary Science

Volumn 93, Issue 2, 2012, Pages 668-674

  Tvarijonaviciute, Asta ^a   Kocaturk, Meric ^b   Cansev, Mehmet ^b   Tecles, Fernando ^a   Ceron, Jose J ^a   Yilmaz, Zeki ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b ULUDAG UNIVERSITY   (Turkey)

Author keywords

BChE; Choline; Dog; Lipopolysaccharide; PON1; S1RS

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CHOLINE; CHOLINESTERASE; ENDOTOXIN; LIPOPOLYSACCHARIDE;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; ENDOTOXEMIA; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME SYNTHESIS; FEMALE; MALE; NONHUMAN;

ANIMALS; ARYLDIALKYLPHOSPHATASE; BODY TEMPERATURE; BUTYRYLCHOLINESTERASE; CHOLINE; DOG DISEASES; DOGS; ENDOTOXEMIA; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIPOPOLYSACCHARIDES; MALE; RESPIRATION;

CANIS FAMILIARIS;

EID: 84863090398     PISSN: 00345288     EISSN: 15322661     Source Type: Journal    
DOI: 10.1016/j.rvsc.2011.09.010     Document Type: Article

References (47)

1. Al-Kassab A.S., Vijayakumar E. Profile of serum cholinesterase in systemic sepsis syndrome (septic shock) in intensive care unit patients. European Journal of Clinical Chemistry and Clinical Biochemistry 1995, 1:11-14.
2. Balk R.A. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Critical Care Clinics 2000, 16:179-192.
3. Blanceil Y., Delaroche O. Diminution de láctivité de la cholinestérase plasmatique au cours des infections bactérienes sévères : comparaison avec celle observée en cas de cirrhose grave. Annales françaises d'anesthèsie et de rèanimation 1996, 15:220-222.
4. Browne R.W., Koury S.T., Marion S., Wilding G., Muti P., Trevisan M. Accuracy and biological variation of human serum paraoxonase 1 activity and polymorphism (Q192R) by kinetic enzyme assay. Clinical Chemistry 2007, 53:310-317.
5. Cansev M., Ilcol Y.O., Yilmaz M.S., Hamurtekin E., Ulus I.H. Peripheral administration of CDP-choline, phosphocholine or choline increases plasma adrenaline and noradrenaline concentrations. Autonomic & Autacoid Pharmacology 2008, 431:71-76.
6. Cansev M., Yilmaz M.S., llcol Y.O., Hamurtekin E., Ulus I.H. Cardiovascular effects of CDP-choline and its metabolites: involvement of peripheral autonomic nervous system. European Journal of Pharmacology 2007, 577:129-142.
7. Ceron J.J., Martinez-Subiela S. An automated spectrophotometric method for measuring canine ceruloplasmin in serum. Veterinary Research 2004, 35:671-679.
8. Ceron P.D., Eckersall, Martinez-Subiela S. Acute phase proteins in dogs and cats: current knowledge and future perspectives. Veterinary Clinical Pathology 2005, 34:85-99.
9. Das U.N. Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation. Medical Science Monitor 2007, 13:214-221.
10. Draganov D., Teiber J., Watson C., Bisgaier C., Nemzek J., Remick D., Standiford T., La Du B. PON1 and oxidative stress in human sepsis and an animal model of sepsis. Advances in Experimental Medicine and Biology 2010, 660:89-97.
11. Feingold K.R., Memon R.A., Moser A.H., Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis 1998, 139:307-315.
12. Gallowitsch-Puerto M., Pavlov V.A. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sciences 2007, 80:2325-2329.
13. Gordon B.R., Parker T.S., Levine D.M., Feuerbach F., Saal S.T., Sloan B.J., Chu C., Stenzel K.H., Parrillo J.E., Rubin A.L. Neutralization of endotoxin by a phospholipids emulsion in healthy volunteers. The Journal of Infectious Diseases 2005, 191:1515-1522.
14. Haagen L., Brock A. A new automated method for phenotyping arylesterase (EC 3.1.1.2) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. European Journal of Clinical Chemistry and Clinical Biochemistry 1992, 30:391-395.
15. Ilcol Y.O., Cansev M., Yilmaz M.S., Hamurtekin E., Ulus I.H. Intraperitoneal administration of CDP-choline and its cholinergic and pyrimidinergic metabolites induce hyperglycemia in rats: involvement of the sympathoadrenal system. Archives of Physiology and Biochemistry 2007, 113:186-201.
16. Ilcol Y.O., Cansev M., Yilmaz M.S., Hamurtekin E., Ulus I.H. Peripheral administration of CDP-choline and its cholinergic metabolites increases serum insulin: muscarinic and nicotinic acetylcholine receptors are both involved in their actions. Neuroscience Letters 2008, 431:71-76.
17. Ilcol Y.O., Gurun M.S., Taga Y., Ulus I.H. Intraperitoneal administration of choline increases serum glucose in rat: involvement of the sympatho-adrenal system. Hormone and Metabolic Research 2002, 34:341-347.
18. Ilcol Y.O., Gurun M.S., Taga Y., Ulus I.H. Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated acetylcholine release from the rat minced pancreas in vitro. European Journal of Biochemistry 2003, 270:991-999.
19. Ilcol Y.O., Yilmaz Z., Cansev M., Ulus I.H. Choline or CDP-choline alters serum lipid responses to endotoxin in dogs and rats: involvement of the peripheral nicotinic acetylcholine receptors. Shock 2009, 32:286-294.
20. Ilcol Y.O., Yilmaz Z., Ulus I.H. Endotoxin alters serum-free choline and phospholipid-bound choline concentrations, and choline administration attenuates endotoxins-induced organ injury in dogs. Shock 2005, 24:288-293.
21. Iwasaki T., Yoneda M., Nakajima A., Terauchi Y. Serum butyrylcholineesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance. Internal Medicine 2007, 46:1633-1639.
22. James R.W., Deakin S.P. The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity. Free Radical Biology and Medicine 2004, 37:1986-1994.
23. Mackness M.I., Arrol S., Durrington P.N. Paraoxonase prevents accumulation of lipoperoxides on low-density lipoprotein. FEBS Letters 1991, 286:152-154.
24. Martinez-Subiela S., Cerón J.J. Analytical validation of commercial assays for haptoglobin, C-reactive protein and serum amyloid in dogs. Archivos de Medicina Veterinaria 2005, 37:61-66.
25. McGreevy P.D., Thomson P.C., Pride C., Fawcett A., Grassi T., Jones B. Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved. The Veterinary Records 2005, 156:695-702.
26. Adib-Conquy M., Cavaillon J.M. Compensatory anti-inflammatory response syndrome. Thrombosis and Haemostasis 2009, 101:36-47.
27. Munro N.B., Shugart L.R., Watson A.P., Halbrook R.S. Cholinesterase activity in domestic animals as a potential biomonitor for nerve agent and other organophosphate exposure. Journal of the American Veterinary Medical Association 1991, 199:103-115.
28. Murch O., Abdelrahman M., Collino M., Gallicchio M., Benetti E., Mazzon E., Fantozzi R., Cuzzocrea S., Thiemermann C. Sphingosylphosphorylcholine reduces the organ injury/dysfunction and inflammation caused by endotoxemia in the rat. Critical Care Medicine 2008, 36:550-559.
29. Nance D.M., Sanders V.M. Autonomic innervation and regulation of the immune system (1987Y2007). Brain, Behavior, and Immunity 2007, 21:736-745.
30. Novak F., Vavrova L., Kodydkova J., Novak F.Sr., Hynkova M., Zak A., Novakova O. Reased paraoxonase activity in critically ill patients with sepsis. Clinical and Experimental Medicine 2010, 10:21-25.
31. Ofek K., Krabbe K.S., Evron T., Debecco M., Nielsen A.R., Brunnsgaad H., Yirmiya R., Soreq H., Pedersen B.K. Cholinergic status modulations in human volunteers under acute inflammation. Journal of Molecular Medicine 2007, 85:1239-1251.
32. Rao A.A., Sridhar G.R., Das U.N. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer's disease. Medical Hypotheses 2007, 69:1272-1276.
33. Rivera C.A., Wheeler M.D., Enomoto N., Thurman R.G. A choline-rich diet improves survival in a rat model of endotoxin shock. The American Journal of Physiology 1998, 275:862-867.
34. Rosas-Ballina M., Tracey K.J. Cholinergic control of inflammation. Journal of Internal Medicine 2009, 265:663-679.
35. Sakaguchi K., Nagayama M., Masaoka T., Nishimura A., Kageyama K., Shirai M., Akahori F. Effects of fenthion, isoxathion, dichlorvos and propaphos on the serum cholinesterase isoenzyme patterns of dogs. Veterinary and Human Toxicology 1997, 39:1-5.
36. Tecles F., Gutiérrez P.C., Martínez-Subiela S., Cerón J.J. Effects of different variables on whole blood cholinesterase analysis in dogs. Veterinary Diagnostic Investigation 2002, 14:132-139.
37. Tecles F., Martinez-Subiela S., Bernal L.J., Ceron J.J. Use of whole blood for spectrophotometric determination of cholinesterase activity in dogs. The Veterinary Journal 2000, 160:242-249.
38. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
39. Tracey K.J. Physiology and immunology of the cholinergic anti-inflammatory pathway. The Journal of Clinical Investigation 2007, 117:289-296.
40. Tvarijonaviciute, A., Tecles, F., Caldin, M., Tasca, S., Cerón, J.J., in press. Validation of spectrophotometric assays for serum paraoxonase type-1 (PON1) measurements in the dog. American journal of veterinary research.
41. Ulus I.H., Millington W.R., Buyukuysal R.L., Kiran B.K. Choline as an agonist: determination of its agonistic potency on cholinergic receptors. Biochemical Pharmacology 1988, 14:2747-2755.
42. Van Amersfoort E.S., Van Berkel T.J.C., Kuiper J. Receptors, mediators, and mechanims envolved in bacterial sepsis and septic shock. Clinical Microbiology Reviews 2003, 16:379-414.
43. Van Lenten B.J., Hama S.Y., de Beer F.C., Stafforini D.M., McIntyre T.M., Prescott S.M., La Du B.N., Fogelman A.M., Navab M. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. Journal of Clinical Investigation 1995, 96:2758-2767.
44. Watson A.D., Berliner J.A., Hama S.Y., La Du B.N., Faull K.F., Fogelman A.M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. The Journal of Clinical Investigation 1995, 96:2882-2891.
45. Yilmaz Z., Ilcol Y.O., Torun S., Ulus I.H. Intravenous administration of choline or CDP-choline improves platelet count and platelet closure times in endotoxin-treated dogs. Shock 2006, 25:73-79.
46. Yilmaz Z., Ilcol Y.O., Eralp O., Cansev M., Kocaturk M., Ulus I.H. Choline or CDP-choline attenuates coagulation abnormalities and prevents the development of acute disseminated intravascular coagulation in dogs during endotoxemia. Blood Coagul & Fibrinolysis 2010, 24:339-348.
47. Zeisel S.H. Choline: critical role during fetal development and dietary requirements in adults. Annual Review of Nutrition 2006, 26:229-250.